Moreover, selective pharmacodynamic readouts to distinguish IKKα- versus IKKβ-regulated signalling were not deployed in the cancer models used [4,26,27,28,29], and apigenin is also known to have effects on cancer-related signalling and phenotypic endpoints via the PI3-kinase/Akt axis [30]. The gene discussed is CHUK; the disease is cancer.